RESUMO
OBJECTIVE: To describe development of mobility and self-care capabilities in young children (aged 1-4 years) with cerebral palsy, and to examine whether the development of mobility and self-care capabilities differs by cerebral palsy severity in terms of 5 distinct Gross Motor Function Classification System (GMFCS) levels. STUDY DESIGN: This prospective longitudinal cohort study included 100 children with cerebral palsy (aged 1.5 or 2.5 years at baseline) and their parents. Mobility and self-care capabilities were assessed by the Pediatric Evaluation of Disability Inventory during yearly assessments from inclusion up to age 4.5 years. Longitudinal data for 92 children were available for analysis. Repeated-measures analyses with random coefficient analysis were performed using linear mixed models. RESULTS: Despite large variations among individuals in the development of mobility and self-care capabilities in young children with cerebral palsy, distinct developmental trajectories were found for children in different GMFCS levels. The estimated change per month differed significantly by GMFCS level for both outcomes. CONCLUSIONS: This longitudinal study provides an evidence base for prognosis in daily mobility and self-care skills in young children with cerebral palsy. The developmental trajectories for GMFCS levels can be helpful in communication between professionals and also in discussions of expectations and goal setting with families regarding mobility and self-care in the daily life of young children with cerebral palsy in neonatal follow-up and pediatric practice.
Assuntos
Paralisia Cerebral/fisiopatologia , Paralisia Cerebral/terapia , Desenvolvimento Infantil , Autocuidado , Paralisia Cerebral/classificação , Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Estudos ProspectivosRESUMO
AIM OF THE STUDY: When people migrate, they tend to bring along their medicinal plants. In order to improve migrant health, we need information on their traditional health beliefs and practices. This paper investigates medicinal plant use among Surinamese migrants in the Netherlands. MATERIALS AND METHODS: Data from 210 semi-structured interviews among 1st and 2nd generation Surinamese migrants were analysed to determine which medicinal plants were used, for what purposes, which demographic, socio-economic or psycho-social factors play a role in the choice for traditional medicine and to clarify people's personal motives to use herbs. Variables associated with medicinal plant use were identified by using the Pearson gamma2 test and the two-sample t-test. After selecting significant variables by means of bivariate analyses, multinomial logistic regression with stepwise forward selection was used to assess whether medicinal plant use could be explained by a combination of these variables. RESULTS: More than 75% of the respondents used herbal medicine, and 66% did so in the past year. Herbs were more frequently employed for health promotion (39%) than for disease prevention or cure (both 27%). Almost half of the respondents who had been ill the last year had used herbal medicine. More than 140 herb species were mentioned during the interviews. Plant use was often related to certain culture-bound health beliefs. Spiritual baths were the most popular traditional practice, followed by genital steam baths, bitter tonics, and the consumption of bitter vegetables. Afro-Surinamers more frequently used herbal medicine than Hindustani. The WINTI belief strongly influenced plant use, as well as the occurrence of an illness in the past year, and frequent visits to Suriname. Age, gender, income and education had no significant effect on the use of traditional medicine. Surinamers stated that they used medicinal herbs because they grew up with them; herbs were more effective and had fewer side effects than conventional therapies. CONCLUSIONS: As long as certain culture-bound beliefs and health concepts remain prevalent among Surinamese migrants, and ties with their home country remain strong, they will continue using medicinal herbs from their country of origin. More research is needed on the health effects of frequently used medicinal plants by migrants in the Netherlands.
Assuntos
Emigrantes e Imigrantes , Conhecimentos, Atitudes e Prática em Saúde , Medicina Herbária , Fitoterapia/estatística & dados numéricos , Plantas Medicinais , Balneologia , Cultura , Etnobotânica , Humanos , Entrevistas como Assunto , Países Baixos , Religião e Medicina , Espiritualidade , Suriname/etnologiaRESUMO
OBJECTIVES: To investigate bacterial colonization and pulmonary function longitudinally in patients with cystic fibrosis (CF) receiving drugs for gastric acid (GA) inhibition for fat malabsorption or for gastroesophageal reflux disease (GERD). STUDY DESIGN: A retrospective cohort study of 218 pediatric patients with CF was performed. Multilevel modeling was used to perform longitudinal analysis of forced expiratory volume in 1 second (FEV(1)), forced vital capacity (FVC), maximum expiratory flow at 50% of FVC (MEF(50)), and maximal mid-expiratory flow between 25% and 75% of FVC (MMEF(25-75)). Cox regression was used to calculate Pseudomonas aeruginosa- and Staphylococcus aureus-free survival. RESULTS: Patients with CF and GA inhibition had a significantly smaller yearly decline of MEF(50) and MMEF(25-75) compared with control subjects. Other pulmonary function parameters and P aeruginosa or S aureus acquisition or colonization were not different from that of control subjects. GERD was associated with a significantly reduced pulmonary function (FEV(1) and FVC) and an earlier acquisition of P aeruginosa and S aureus. CONCLUSIONS: GA inhibition did not affect pulmonary function or bacterial acquisition and therefore is not contraindicated in patients with CF. GA inhibition might improve pulmonary function with time, because the decline of MEF(50) and MMEF(25-75) was less pronounced. GERD was associated with a reduced pulmonary function and an earlier acquisition of P aeruginosa and S aureus. Therefore the diagnosis and treatment of GERD should be aggressively pursued in patients with CF.